Michael Grey, Director at BioMarin Pharmaceutical, holds 280.16K shares in Mirum Pharmaceuticals (Ticker: MIRM), holds 628.85K shares in OnKure Therapeutics (Ticker: OKUR), holds 42.84K shares in BioMarin Pharmaceutical (Ticker: BMRN).
Michael Grey latest transaction was an Uninformative Sell of ―.
What was Michael Grey's most profitable transaction?
Michael Grey’s most profitable transaction was an Informative Buy of HZNP stock on May 10, 2017. The return on the trade was 42.30%.
What is Michael Grey's role in BioMarin Pharmaceutical?
Michael Grey's role in BioMarin Pharmaceutical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.